Suchergebnisse - "Halfmann, Peter J"

PubPharm (106)

61

Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model

enthalten in: Cell reports | 2022

von Halfmann, P. | Kuroda, M. | Armbrust, T. | +6

62

Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron

enthalten in: bioRxiv : the preprint server for biology | 2022

von Chong, Z. | Karl, C. | Halfmann, P. | +4

UpdateIn: Cell Rep. 2022 Apr 21;:110799. - PMID 35523172

63

SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters

enthalten in: The Journal of infectious diseases | 2022

von Halfmann, P. | Nakajima, N. | Sato, Y. | +8

64

Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike

enthalten in: mBio | 2021

von Changrob, S. | Fu, Y. | Guthmiller, J. | +17

UpdateOf: Res Sq. 2021 Jul 19;:. - PMID 34312615

65

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

enthalten in: bioRxiv : the preprint server for biology | 2021

von Cameroni, E. | Saliba, C. | Bowen, J. | +53

UpdateIn: Nature. 2021 Dec 23;:. - PMID 35016195

66

Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck

enthalten in: bioRxiv.org | 2021

von Braun, K. | Moreno, G. | Halfmann, P. | +12

67

Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes : Spike Protein-Mediated Cell Fusion and Its Inhibition

enthalten in: Journal of virology | 2021

von Navaratnarajah, C. | Pease, D. | Halfmann, P. | +9

68

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2

enthalten in: Viruses | 2021

von Sakai-Tagawa, Y. | Yamayoshi, S. | Halfmann, P. | +1

69

Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages

enthalten in: mBio | 2021

von Maemura, T. | Kuroda, M. | Armbrust, T. | +3

70

RECOMBINANT BIOLOGICALLY CONTAINED FILOVIRUS VACCINE

enthalten in: Europäisches Patentamt | 2021

von KAWAOKA ET AL YOSHIHIRO | HALFMANN PETER J